Page last updated: 2024-09-03

ici 153066 and rifampin

ici 153066 has been researched along with rifampin in 1 studies

Compound Research Comparison

Studies
(ici 153066)
Trials
(ici 153066)
Recent Studies (post-2010)
(ici 153066)
Studies
(rifampin)
Trials
(rifampin)
Recent Studies (post-2010) (rifampin)
190020,4681,4996,552

Protein Interaction Comparison

ProteinTaxonomyici 153066 (IC50)rifampin (IC50)
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.949
Caspase-1Homo sapiens (human)8.319
Alpha-synucleinHomo sapiens (human)7.1
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv0.03
DNA-directed RNA polymerase subunit betaMycobacterium tuberculosis H37Rv0.01
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR1

Other Studies

1 other study(ies) available for ici 153066 and rifampin

ArticleYear
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Rifampin; Triazoles

1984